|
Index of reports
> Cases with Dyspnoea (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Corzide (Nadolol / Bendroflumethiazide) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Corzide side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-28
Patient: 65 year old male
Reactions: Dyspnoea, Atrial Fibrillation, Crepitations, Arrhythmia, Lower Respiratory Tract Infection, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Corzide
Indication: Product Used FOR Unknown Indication
End date: 2012-01-31
Abiraterone Acetate
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-01-16
Ramipril
Administration route: Oral
Indication: Product Used FOR Unknown Indication
End date: 2012-01-31
Other drugs received by patient: Metoclopramide; Goserelin; Oxycodone HCL; Lansoprazole
Possible Corzide side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-27
Patient: 65 year old male
Reactions: Dyspnoea, Crepitations, Atrial Fibrillation, Condition Aggravated, Lower Respiratory Tract Infection, Renal Failure Acute, Arrhythmia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Corzide
Dosage: 5 mg, qd
End date: 2012-01-31
Ramipril
Dosage: 2.5 mg, qd
Administration route: Oral
End date: 2012-01-31
Abiraterone
Dosage: 1 g, unk
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-01-16
Other drugs received by patient: Lansoprazole; Oxycodone HCL; Goserelin; Metoclopramide
Possible Corzide side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-23
Patient: 65 year old male
Reactions: Dyspnoea, Crepitations, Atrial Fibrillation, Renal Failure Acute, Lower Respiratory Tract Infection, Arrhythmia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zytiga
Dosage: 1 g, unk
Administration route: Oral
Indication: Prostate Cancer Metastatic
Start date: 2012-01-16
Ramipril
Dosage: 2.5 mg, 1x/day
Administration route: Oral
End date: 2012-01-31
Corzide
Dosage: 5 mg, 1x/day
End date: 2012-01-31
Other drugs received by patient: Oxycodone; Lansoprazole; Goserelin; Metoclopramide
|
